---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-091610"
form_type: "8-K"
ticker: "BVS"
cik: "0001665988"
company_name: "Bioventus Inc."
filed_at: "2023-04-05T23:59:59+00:00"
generated_at: "2026-06-17T05:53:02.506417+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Bioventus CEO Kenneth Reali departs; Anthony Bihl named interim CEO

## Summary
- CEO Kenneth Reali transitioned from role on April 3, 2023; resigned as director and officer on April 4.
- Anthony P. Bihl III appointed interim CEO and Class III director effective April 5, 2023.
- Bihl previously served as CEO of Bioventus LLC (2013-2020) and has public board experience.
- Separation agreement provides severance: 18 months base salary, 150% of target bonus, COBRA.
- Company states Reali's departure is not related to its operations, policies, or practices.

## SEC filing metadata
- accession: 0001193125-23-091610
- form_type: 8-K
- ticker: BVS
- cik: 0001665988
- company_name: Bioventus Inc.
- filed_at: 2023-04-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1665988/000119312523091610/0001193125-23-091610-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1665988/000119312523091610/d474824d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-091610
- JSON: https://secwatch.observer/filing/0001193125-23-091610.json
- Plain text: https://secwatch.observer/filing/0001193125-23-091610.txt

## Key facts
- Executive change
  Anthony P. Bihl III was appointed as Interim Chief Executive Officer at Bioventus Inc..
  - Action: appointed
  - Role: Interim Chief Executive Officer
  source text: On April 4, 2023, Anthony P. Bihl III was appointed as Interim Chief Executive Officer of the Company and as a Class III director of the Company, effective April 5, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1665988/000119312523091610/0001193125-23-091610-index.htm
- Executive change
  Anthony P. Bihl III was appointed as Class III director at Bioventus Inc..
  - Action: appointed
  - Role: Class III director
  source text: On April 4, 2023, Anthony P. Bihl III was appointed as Interim Chief Executive Officer of the Company and as a Class III director of the Company, effective April 5, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1665988/000119312523091610/0001193125-23-091610-index.htm
- Executive change
  Kenneth Reali resigned as director at Bioventus Inc..
  - Action: resigned
  - Role: director
  source text: On April 3, 2023, the Board of Directors (the “Board”) of Bioventus Inc. (the “Company”) informed Kenneth Reali that it had determined that he would transition from his role as Chief Executive Officer of the Company and, on April 4, 2023, Mr. Reali resigned as a director and officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1665988/000119312523091610/0001193125-23-091610-index.htm
- Executive change
  Kenneth Reali resigned as Chief Executive Officer at Bioventus Inc..
  - Action: resigned
  - Role: Chief Executive Officer
  source text: On April 3, 2023, the Board of Directors (the “Board”) of Bioventus Inc. (the “Company”) informed Kenneth Reali that it had determined that he would transition from his role as Chief Executive Officer of the Company and, on April 4, 2023, Mr. Reali resigned as a director and officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1665988/000119312523091610/0001193125-23-091610-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.